Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?

Coronary Artery Disease

Volumn 18, Issue 4, 2007, Pages 293-298

  Li, Jian Jun ^a   Xu, Bo ^a   Yang, Yue Jin ^a   Chen, Ji Lin ^a   Qiao, Shu Bing ^a   Ma, Wei Hua ^a   Qin, Xue Wen ^a   Yao, Min ^a   Liu, Hai Bo ^a   Wu, Yong Jian ^a   Yuan, Jin Qing ^a   Chen, Jue ^a   You, Shi Jie ^a   Dai, Jun ^a   Xia, Ran ^a   Gao, Run Lin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Angiography; Coronary artery disease; Restenosis; Sirolimus eluting stent

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTENOSIS; THROMBOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 34248361945     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32812cba31     Document Type: Article

References (18)

1. Sigwart W. Drug-eluting stents are safety and effective: right or wrong? J Am Coll Cardiol 2006;47:1491-1494.
2. Li J-J, Xu B, Yang Y-J, Ma W-H, Chen J-L, Qiao S-B, et al. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-steent restenosis. Chin Med J 2006; 119:1059-1064.
3. Sidhu S, Shafiq N, Malhotra S, Pandhi P, Grover A. A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease. Br J Clin Pharmacol 2006; 61:720-726.
4. Xu B, Li J-J, Yang Y-J, Ma W-H, Chen J-L, Qiao S-B, et al. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han population. Chin Med J 2006; 119:533-538.
5. Kastrati A, Schömig A, Dietz R, Neumann FJ, Richardr G. Time course of restenosis during the first year after emergency coronary stent. Circulation 1993; 87:1498-1505.
6. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Moon DH, et al. Late intravascular ultrasound findings of patients treated with brachytherapy for diffuse in-stent restenosis. Catheter Cardiovasc Inter 2004; 63:208-214.
7. Feres F, Munoz J, Abizaid A, Staico R, Kuwabara M, Mattos L, et al. Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after introcoronary beta-radiation for the treatment of in-stent restenosis. J Invasive Cardiol 2005; 17:473-477.
8. Wessely R, Kastrati A, Schömig A. Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med 2005; 143:392-394.
9. Valgimigli M, Malagutti P, van Mieghem CAG, Vaina S, Ligthart JM, Sianos G, Serruys PW. Persistence of neointimal growth 12 months after intervention and occurrence of delayed restenosis in patients with left main coronary artery disease treated with drug-eluting stents. J Am Coll Cardiol 2006; 47:1491-1494.
10. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004; 63:617-624.
11. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, et al., REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 2006; 295:895-904.
12. Vijayakumar M, Lemos PA, Hoye A, Ong ATL, Aoki J, Granillo GR, et al. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians. Am J Cardiol 2004; 94:909-913.
13. Schofer M, Schluter AH, Gershlick W, Wijns E, Garcia E, Schampaert G, Breithardt G, E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet 2003; 362:1093-1099.
14. Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim mDW, Ware M Jr, et al. Paclitaxel stent coating inhibits neointimal hyperlasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001; 103:2289-2295.
15. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, et al. Stent-based delivery of sirolimus reduces neointimal formation in a procine coronary model. Circulation 2001; 104:1188-1193.
16. Virmani R, Farb A, Guagliumi G, Kolodhia FD. Drug-eluting stents caution and concerns for long-term outcome. Coron Artery Dis 2004; 15:313-318.
17. Feres F, Munoz J, Abizaid A. Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after introcoronary beta-radiation for the treatment of in-stent restenosis. J Invasive Cardiol 2005; 17:473-477.
18. Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S, et al. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 2002; 105:1883- 1886.